Insights into Company Bills & Payments

Tata Consumer Products ↗

1962 📍 Kolkata, West Bengal, India Active NSE TATACONSUM CIN L15491WB1962PLC031425 Food & Beverages
Search companies

Key Metrics of Tata Consumer Products

Revenue₹14,700 Cr▲ 14.8% YoYFY 2025-26
EBITDA₹2,367 Cr▲ 23.1% YoY
Net profit₹1,635 Cr▲ 30.3% YoY
Net worth₹17,805 Cr▲ 4.7% YoY
Competitors10identified

About Tata Consumer Products

Sectors

Food & BeveragesDal & PulsesPackaged Foods & Confectionery

Company details

Website
tataconsumer.com
Founded
1962
Registered office
Tata Centre, 1st Floor, 43, Jawaharlal Nehru Road, Middleton Row, Kolkata, Kolkata, In-wb, 700071
Listed
NSE: TATACONSUM · ₹1,025.90

Operational Areas of Tata Consumer Products

Food & Beverages›Dal & Pulses

Company summary

Entity details

CINL15491WB1962PLC031425
LEI code335800LOXFWU8ZQJMD12
State codeWB
PIN code700071
Current legal nameTATA CONSUMER PRODUCTS
Classification—
Listing statusListed (NSE: TATACONSUM)
Registration no.031425
Company age64 years, 10 months
PAN—
CountryIndia
CityKolkata
StateWest Bengal
Current statusActive
Date of incorporation01 Jan 1962
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueMGT-7 for FY 2025-26 · 29 Nov 2026

Industry classification

NIC code15491
Description of main activityManufacture of food products and beverages
Description of business activityManufacture of food products and beverages
SectorFood & Beverages · Dal & Pulses

Share price · NSE: TATACONSUM

TATACONSUM on NSE

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date passed
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 27 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 06 Oct 2026 CARE A1+ Reaffirmed
ICRA · 30 Apr 2026 ICRA AAA Stable outlook · Short term A1+ · Reaffirmed
Change in last 12 months—
Change since first rating on record—since May 2019
Rating actions120 up · 0 down
Liquidity (CARE)Strong

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
06 Oct 2026CAREReaffirmed —A1+—₹1,500 Cr View
30 Apr 2026ICRAReaffirmed AAAA1+Stable₹2,350 Cr View
07 Oct 2025CAREReaffirmed —A1+—₹1,500 Cr View
22 Jan 2025CAREReaffirmed —A1+—₹1,500 Cr View
23 Jan 2024CAREOther ———— View
25 Jul 2023CAREOther ———— View
04 Aug 2022CAREReaffirmed —A1+—₹1,430 Cr View
05 Aug 2021CAREReaffirmed —A1+—₹715 Cr View
06 Jul 2021CAREOther ———— View
07 Jul 2020CAREOther ———— View
05 Jul 2019CAREOther —A1+—₹715 Cr View
24 May 2019CAREOther ———— View

Credit strengths (CARE, Oct 2026)

+ Established brands with diversified product offerings and global presence

TCPL benefits from a portfolio of well -established brands with leadership positions across multiple product categories and geographies, underpinning its strong business profile. In India, the company enjoys a leading presence in branded tea and sal t 1SEBI: Securities and Exchange Board of India; RBI: Reserve Bank of India; MCA: Ministry of Corporate Affairs; IRDAI: Insuranc e Regulatory and Development Authority of India; PFRDA: Pension Fund Regulatory and Development Authority.

+ Sustained growth in the company’s scale of operations, while maintaining its operating margins

TCPL’s TOI grew at a CAGR of 13% for four years ended FY26, reaching ₹20,290 crore in FY26, driven by sustained organic growth across its portfolio and strategic acquisitions, with FY26 recording a growth of 15% on a year-over-year (y-o-y) basis. The company’s India branded business grew by 14% on a y -o-y basis to ₹12,779 crore in FY26, driven by steady growth in the core tea and salt portfolios and continued strong traction in growth businesses. While core businesses grew by ~10%, the growth

+ Comfortable financial risk profile

TCPL’s financial risk profile remains strong, supported by its sizeable net worth of over ₹23,000 crore (including acquired goodwill and intangible assets related to acquisition) , robust cash flow generation , and limited reliance on external borrowings. Following the ₹2,995 crore rights issue and repayment of acquisition-related debt raised for Capital Foods and Organic India in FY25, the company has maintained a net debt negative position for two years ended FY26. TCPL’s overall gearing and t

Credit challenges

− Moderate return on capital employed

TCPL continues to invest in inorganic growth opportunities to strengthen its product portfolio, expand brand presence, and enhance category diversification. Significant investments towards strategic acquisitions in the past, including Capital Foods and Organic India in recent time, have led to sizeable capital deployment in the last few years. Consequently, return indicators remained moderate, with consolidated ROCE at 11.36% in FY26 (FY25: 9.43%). CareEdge Ratings expects ROCE to remain

− Exposure to commodity, currency, and competitive risks

TCPL’s profitability remains susceptible to volatility in tea and coffee prices, foreign exchange fluctuations, and intense c ompetition across its key categories. The sharp rise in domestic tea prices and green coffee costs in the US exerted pressure on ma rgins; however, the impact was partially offset through calibrated price increases, premiumisation, cost optimisation initiatives, a nd dynamic sourcing strategies. Commodity risks are mitigated through active tea procurement management and s

Could lead to a downgrade

• Major debt-funded capital expenditure/inorganic growth and delay in profitably ramping up revenues from such investments, which may weaken profitability indicators, capital structure or

Agency-reported financials (CARE, 06 Oct 2026)

MetricMarch 31, 2025March 31, 2026
Total operating income₹20,290 Cr₹5,349 Cr
PBILDT*₹2,792 Cr₹724 Cr
Profit after tax (PAT)₹1,547 Cr₹427 Cr
Overall gearing (x)0.12×—
Interest coverage (x)20.37×18.52×
Revenue growth (YoY)—−73.6%
PAT margin7.6%8.0%

Borrowings & rated debt

Rated borrowing limits (latest)₹2,350 Cr
Peak rated limits₹2,350 CrApr 2026 · ICRA
Limits raised0 times0 new facilities rated

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Long-term Short-term Fund-based Non-fund-based – Working Capital FacilitiesNon-fund based limits₹850 Cr₹850 Cr0.0% AAA / A1+ (Stable)ReaffirmedICRA
Short-term – Interchangeable Limits (50.00) (150.00) Short term – Commercial PaperCommercial paper₹1,500 Cr₹1,500 Cr0.0% A1+ReaffirmedICRA

Debt instruments

ISINInstrumentTypeCouponIssuedMaturityAmountRatingStatus
INE192A14838Sep Dec +Commercial paper5.94% —— ₹100 CrA1+ Not stated
INE192A14846Sep Dec +Commercial paper5.95% —— ₹150 CrA1+ Not stated
INE192A14721Dec Feb +Commercial paper7.17% —— ₹200 CrA1+ Not stated
INE192A14739Dec Feb +Commercial paper7.19% —— ₹100 CrA1+ Not stated
INE192A14358Dec Mar +Commercial paper7.45% —— ₹50.0 CrA1+ Not stated
INE192A14366Dec Mar +Commercial paper7.42% —— ₹100 CrA1+ Not stated
INE192A14374Dec Mar +Commercial paper7.47% —— ₹50.0 CrA1+ Not stated
INE192A14382Dec Mar +Commercial paper7.47% —— ₹50.0 CrA1+ Not stated
INE192A14390Jan Mar +Commercial paper7.32% —— ₹50.0 CrA1+ Not stated
INE192A14408Jan Mar +Commercial paper7.34% —— ₹50.0 CrA1+ Not stated

CARE ratings on record (checked 24 Oct 2026)

InstrumentAmountRating
Commercial Paper (Standalone)—Withdrawn
CP/ Short Term loan—Withdrawn
CP/ Short Term loan₹1,500 CrCARE A1+

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityStrongAgency: Strong
DirectionRating watch – Developing
CARE rating · Oct 2026—

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Next action stable or better (model)72%
Information on file78% · missing: Capex / investment plans, Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further funding possible with conditions Next rating action stable or better: 56% (At risk of downgrade) · ML model on 6893 rating histories, AUC 0.653
Rated limits₹1,500 Cr
Not yet allocated—
Extra debt within 2.5× EBITDA—
Interest coverage18.52×
Limit utilisation10%
Open bank charges0 · —
  • Credit outlook model: 56% chance the next rating action is stable or better
  • Interest coverage 18.52×
  • Working-capital limits 10% utilised on average

What happened, step by step

Refinanced bank debt with equity
  1. Oct 2026 — ₹2,995 cr raised through equity
  2. Oct 2026 — Full repayment of debt

“Following the ₹2,995 crore rights issue and repayment of acquisition-related debt raised for Capital Foods and Organic India in FY25, the company has maintained a net debt negative position for two years ended FY26.”

Rated limits by facility

Timeline

06 Oct 2026 CARE reaffirmed: A1+Rated limits ₹1,500 cr CARE rationale
06 Oct 2026 ₹2,995 cr raised through equity
From the report

Following the ₹2,995 crore rights issue and repayment of acquisition-related debt raised for Capital Foods and Organic India in FY25, the company has maintained a net debt negative position for two years ended FY26.

CARE rationale
06 Oct 2026 Full repayment of debt
From the report

Repayment of debt availed for acquisition in FY25, translated into a significant improvement in the PBILDT interest coverage ratio to 20.37x in FY26 from 8.54x in FY25, while total debt to PBILDT (TD/PBILDT) remained healthy at 1.01x (FY25: 0.97x).

CARE rationale
06 Oct 2026 Cash & liquid funds ₹2,400 cr
From the report

Consolidated cash flow from operations stood at around ₹2,400 crore in FY26.

CARE rationale
06 Oct 2026 Cash & liquid funds ₹4,200 cr, undrawn lines ₹500 cr
From the report

The company’s liquidity is further bolstered by free cash and liquid investments of over ₹4,200 crore as on March 31, 2026, and unutilised bank working capital limits exceeding ~₹500 crore on a standalone basis.

CARE rationale
06 Oct 2026 Average working-capital utilisation 10%
From the report

Average utilisation of fund-based working capital facilities remained low at ~10% for 12 months ended August 2026, providing significant financial headroom.

CARE rationale
30 Apr 2026 ICRA reaffirmed: AAA (Stable)Rated limits ₹2,350 cr ICRA rationale
30 Apr 2026 Cash & liquid funds ₹2,000 cr
From the report

TCPL, on a consolidated basis, has sizeable free cash and liquid investments, which stood at more than Rs. 2,000 crore as on September 30, 2025.

ICRA rationale
07 Oct 2025 CARE reaffirmed: A1+Rated limits ₹1,500 cr CARE rationale
07 Oct 2025 Cash & liquid funds ₹1,925 cr
From the report

TCPL had healthy cash accruals of ₹1,925 crore in FY25 and liquid investments amounting to ₹3,089 crore (mainly invested in deposits and mutual funds) as on March 31, 2025.

CARE rationale
07 Oct 2025 Debt repayments due: ₹45 cr
From the report

In FY25, the company generated cash accruals of over ₹1,925 crore against scheduled debt repayment obligation of ₹45 crore (excluding lease liabilities).

CARE rationale
07 Oct 2025 Cash & liquid funds ₹2,200 cr
From the report

Given the expectation of continued strong cash accruals of ~₹2,200 crore in FY26, CareEdge Ratings expects it to comfortably meet its debt obligations.

CARE rationale
07 Oct 2025 Cash & liquid funds ₹3,089 cr
From the report

The company has robust liquidity position marked by cash and liquid investments of over ₹3,089 crore as on March 31, 2025, which provides additional support.

CARE rationale
07 Oct 2025 New borrowing arranged: ₹500 cr (term loans)
From the report

Of the total sanctioned limit, ~80% (or over ₹500 crore) remained unutilised and is available to support incremental working capital requirements in the next year.

CARE rationale
22 Jan 2025 CARE reaffirmed: A1+Rated limits ₹1,500 cr CARE rationale
22 Jan 2025 Cash & liquid funds ₹1,518 cr
From the report

TCPL had healthy cash accruals of ₹1,518 crore in FY24 and liquid investments amounting to ₹2,877 crore (mainly invested in deposits and mutual funds) as on March 31, 2024.

CARE rationale
22 Jan 2025 New borrowing arranged (term loans)
From the report

The increase in short-term debt due to the bridge finance availed for the recent acquisition resulted in overall increase in debt levels as on March 31, 2024.

CARE rationale
22 Jan 2025 Cash & liquid funds ₹2,877 cr
From the report

TCPL has cash and liquid investments to the tune of ₹2,877 crore (consolidated level) as on March 31, 2024 and ₹2,521 crore as on September 30, 2024.

CARE rationale
22 Jan 2025 ₹2,997.77 cr raised through equity
From the report

It has repaid the short-term debt availed for the acquisitions in FY24 with the funds raised through rights issue amounting to ₹2,997.77 crore.

CARE rationale
22 Jan 2025 New borrowing arranged: ₹2,997.77 cr (equity)
From the report

It has repaid the short-term debt availed for the acquisitions in FY24 with the funds raised through rights issue amounting to ₹2,997.77 crore.

CARE rationale
22 Jan 2025 New borrowing arranged: ₹562 cr (term loans)
From the report

Further, the company has ₹562 crore of sanctioned working capital limits which remains unutilised to the extent of 70-75%, hence providing the company additional liquidity.

CARE rationale
23 Jan 2024 CARE other: — CARE rationale
23 Jan 2024 Cash & liquid funds ₹1,450 cr
From the report

The gross cash accruals (GCA) improved fr om ₹1,450 crore in FY22 to ₹1,601 crore in FY23.

CARE rationale
23 Jan 2024 Cash & liquid funds ₹1,385 cr
From the report

The company has cash (₹1,385 crore) and bank balance (₹1,123 crore) and current investments (₹537 crore) to the tune of ₹3,045 crore on consolidated level on Sept 2023.

CARE rationale
25 Jul 2023 CARE other: — CARE rationale
25 Jul 2023 New borrowing arranged (term loans)
From the report

Also, TCPL’s liquidity profile continues to remain strong, with negative net debt position and largely unutilised sanctioned working capital limits.

CARE rationale
25 Jul 2023 Cash & liquid funds ₹1,450 cr
From the report

The gross cash accruals (GCA) improved from ₹1,450 crore in FY22 to ₹1,601 crore in FY23.

CARE rationale
25 Jul 2023 Cash & liquid funds ₹2,782 cr
From the report

The company has cash and bank balance (₹2,782 crore) and liquid investments (₹755 crore) to the tune of ₹3,537 crore on consolidated level on March 2023.

CARE rationale
25 Jul 2023 New borrowing arranged: ₹400 cr (term loans)
From the report

Furthermore, the company has sanctioned fund-based working capital limits amounting to ₹400 crore, which is mostly unutilised, providing the company additional liquidity.

CARE rationale
25 Jul 2023 Debt repayments due in FY24: ₹65 cr
From the report

During FY2 3, the company generated GCA of ₹1, 601 crore against total long -term debt repayment obligations of ₹ 65 crore for FY24.

CARE rationale
25 Jul 2023 New borrowing arranged (term loans)
From the report

Furthermore, the company has sanctioned fund-based working capital limits, which is mostly unutilised, providing the company additional liquidity.

CARE rationale
04 Aug 2022 CARE reaffirmed: A1+Rated limits ₹1,430 cr CARE rationale
04 Aug 2022 New borrowing arranged (term loans)
From the report

TCPL’s liquidity profile continues to remain strong, with negative net debt position and largely unutilised sanctioned working capitallimits.

CARE rationale
04 Aug 2022 Cash & liquid funds ₹1,404 cr
From the report

The gross cash accruals (GCA) improved from ₹1,404 crore in FY21 to ₹1,450 crore in FY22. 1Complete definition of the ratings assigned are available at www.careedge.in and other CARE Ratings Ltd.’s publications 1 CARE Ratings Ltd.

CARE rationale
04 Aug 2022 Cash & liquid funds ₹2,798 cr
From the report

Liquidity: Strong The liquidity is marked by stable cash accruals and comfortable cash and cash equivalents and liquid investments to the tune of ₹2,798 crore on consolidated basis (including ₹521 crore bank overdraft).

CARE rationale
04 Aug 2022 Debt repayments due in FY23: ₹56 cr
From the report

During FY22, the company generated GCA of ₹1,450 crore against total long-term debt repayment obligations of ₹56 crore for FY23.

CARE rationale
04 Aug 2022 New borrowing arranged (term loans)
From the report

Furthermore, the company has sanctioned fund-based working capital limits, which is mostly unutilised, providing the company additional liquidity.

CARE rationale
05 Aug 2021 CARE reaffirmed: A1+Rated limits ₹715 cr CARE rationale
05 Aug 2021 New borrowing arranged: ₹715 cr (commercial paper)
From the report

Seven Hundred Fifteen Crore Only) Details of instruments/facilities in Annexure -1 @ Total borrowing under CP and fund based facilities from banks to remain within an overall limit of Rs. 715 crore out of which Tata Consumer Products Limited has a sanctioned fund based working capital limit of Rs.400 cr ore Detailed Rationale & Key Rating Drivers The rating assigned to the Commercial Paper Issue of Tata Consumer Products Limited (TCPL) continues to factor in its strong business profile with well established brands and market position across geographies.

CARE rationale
05 Aug 2021 New borrowing arranged (term loans)
From the report

TCPL’s liquidity profile continues to remain strong with negative net debt position and largely unutilized sanctioned working capital limits.

CARE rationale
05 Aug 2021 Cash & liquid funds ₹3,320 cr
From the report

Liquidity: Strong Liquidity is marked by stable cash accruals and comfortable cash & liquid investments to the tune of Rs. 3,320 crore on consolidated basis (Rs. 1,916 crore on standalone basis) as on March 31, 2021.

CARE rationale
06 Jul 2021 CARE other: — CARE rationale
06 Jul 2021 New borrowing arranged: ₹715 cr (commercial paper)
From the report

Seven Hundred Fifteen crore only) (A One Plus) Details of instruments/facilities in Annexure -1 @ Total borrowing under CP and fund based facilities from banks to remain within an overall limit of Rs. 715 crore out of which Tata Consumer Products Limitedhas a sanctioned fund based working capital limit of Rs.400 crore Detailed Rationale& Key Rating Drivers The rating assigned to the Commercial Paper Issue of Tata Consumer Products Limited (TCPL) continues to factor in its strong business profile which has further strengthened with acquisition of consumer business of Tata Chemicals Limited.

CARE rationale
06 Jul 2021 New borrowing arranged (term loans)
From the report

TCPL’s liquidity profile continues to remain superior with negative net debt position and largely unutilized sanctioned WC limits.

CARE rationale
06 Jul 2021 Cash & liquid funds ₹3,300 cr
From the report

Company continues to maintain robust liquidity with cash and cash equivalent of more than Rs. 3300 crore on consolidated basis as on March 31, 2021 (on standalone basis,close to Rs. 1900 crore) and maintains negative net d ebt position.

CARE rationale
07 Jul 2020 CARE other: — CARE rationale
07 Jul 2020 New borrowing arranged: ₹715 cr (commercial paper)
From the report

Seven Hundred Fifteen crore only) (A One Plus) Details of instruments/facilities in Annexure-1 @ Total borrowing under CP and fund based facilities from banks to remain within an overall limit of Rs. 715 croreout of which Tata Consumer Products Limitedhas a sanctioned fund based working capital limit of Rs.400 crore Detailed Rationale& Key Rating Drivers The rating assigned to the Commercial Paper Issue of Tata Consumer Products Limited (TCPL) continues to derive strength from its superior liquidity position marked byimproving cash accruals,high cash and bank balance and largely unutilized san

CARE rationale
07 Jul 2020 Cash & liquid funds ₹2,443 cr
From the report

Company continues to maintain robust liquidity with cash and bank balance of Rs. 2443 crore on consolidated basis as on Mar 31, 2020 (on standalone basis, cash balance of Rs. 1462 crore) and maintains negative net debt position .

CARE rationale
07 Jul 2020 New borrowing arranged: ₹400 cr (term loans)
From the report

Of Rs. 400 crore sanctioned WC limits, utilization level remains below 7% for 12 months ending Mar’20.

CARE rationale
05 Jul 2019 CARE other: A1+Rated limits ₹715 cr CARE rationale
05 Jul 2019 Cash & liquid funds ₹1,862 cr
From the report

TGBL has high cash and liquid investments to the tune of Rs. 1862 crore against total debt of Rs. 1141.1 crores consequent into net cash surplus and low working capital utilization.

CARE rationale
05 Jul 2019 ₹715 cr of limits rated but not yet allocated to a lender CARE rationale
24 May 2019 CARE other: — CARE rationale
24 May 2019 Cash & liquid funds ₹1,862 cr
From the report

TGBL holds cash & bank balance and liquid investments in mutual funds to the tune of around Rs. 1862 crores against total debt of Rs. 1141.1 crore as on march 31, 2019 on a consolidated basis.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeTATA CENTRE, 1ST FLOOR, 43, JAWAHARLAL NEHRU ROAD, MIDDLETON ROW, KOLKATA, KOLKATA, IN-WB, 700071
GSTIN—
Email—
Websitehttps://www.tataconsumer.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Tata Consumer Products

Competitors10identified
Locations4most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Patanjali Foods Dal & Pulses · Food & Beverages patanjalifoods.com — Mumbai, India
Swiggy E-commerce · Food Delivery swiggy.com 2014 Bangalore, India
Britannia Industries Biscuits & Bakery · Food & Beverages britannia.co.in 1892 Kolkata, India
KRBL Dal & Pulses · Food & Beverages krblrice.com — Delhi, India
Heritage Foods Dairy, Ghee & Milk Products · Food & Beverages heritagefoods.in 1992 Hyderabad, India
Hindustan Foods Limited · Manufacturing (Food stuffs) — — Mumbai, Maharashtra, India
Zydus Wellness Packaged Foods & Confectionery · Food & Beverages zyduswellness.com — Ahmedabad, India
Dhampur Bio Organics Limited · Manufacturing (Food stuffs) — — Moradabad, Uttar Pradesh, India
Sapphire Foods India Limited Packaged Foods & Confectionery · Food & Beverages sapphirefoods.in — Panchkula, Haryana, India
Gujarat Tea Processors & Packers Ltd Packaged Foods & Confectionery · Food & Beverages waghbakritea.com 1915 India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Group companies

Business activities and related parties

Unpolished dals, besan, spices, salt, tea and coffee

Filings

No filings on record yet.